Hanping Feng, Ph.D. - Publications

Affiliations: 
2002 University of Arizona, Tucson, AZ 
Area:
Immunology, Oncology, Microbiology Biology

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Chen S, Wang H, Gu H, Sun C, Li S, Feng H, Wang J. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B. Toxins. 8. PMID 27537911 DOI: 10.3390/toxins8080241  0.92
2016 Mehta KK, Paskaleva EE, Wu X, Grover N, Mundra RV, Chen K, Zhang Y, Yang Z, Feng H, Dordick JS, Kane RS. Newly identified bacteriolytic enzymes that target a wide range of clinical isolates of Clostridium difficile. Biotechnology and Bioengineering. PMID 27260850 DOI: 10.1002/bit.26029  0.92
2015 Yu H, Chen K, Wu J, Yang Z, Shi L, Barlow LL, Aronoff DM, Garey KW, Savidge TC, von Rosenvinge EC, Kelly CP, Feng H. Identification of toxemia in patients with Clostridium difficile infection. Plos One. 10: e0124235. PMID 25885671 DOI: 10.1371/journal.pone.0124235  0.92
2015 Huang T, Perez-Cordon G, Shi L, Li G, Sun X, Wang X, Wang J, Feng H. Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells. Pathogens and Disease. 73. PMID 25743476 DOI: 10.1093/femspd/ftv008  0.52
2015 Li S, Shi L, Yang Z, Zhang Y, Perez-Cordon G, Huang T, Ramsey J, Oezguen N, Savidge TC, Feng H. Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis. Infection and Immunity. 83: 502-13. PMID 25404023 DOI: 10.1128/IAI.02316-14  0.92
2014 Huang T, Li S, Li G, Tian Y, Wang H, Shi L, Perez-Cordon G, Mao L, Wang X, Wang J, Feng H. Utility of Clostridium difficile toxin B for inducing anti-tumor immunity. Plos One. 9: e110826. PMID 25340750 DOI: 10.1371/journal.pone.0110826  0.52
2014 Yang Z, Schmidt D, Liu W, Li S, Shi L, Sheng J, Chen K, Yu H, Tremblay JM, Chen X, Piepenbrink KH, Sundberg EJ, Kelly CP, Bai G, Shoemaker CB, ... Feng H, et al. A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice. The Journal of Infectious Diseases. 210: 964-72. PMID 24683195 DOI: 10.1093/infdis/jiu196  0.92
2012 Butler MM, Shinabarger DL, Citron DM, Kelly CP, Dvoskin S, Wright GE, Feng H, Tzipori S, Bowlin TL. MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile. Antimicrobial Agents and Chemotherapy. 56: 4786-92. PMID 22733075 DOI: 10.1128/AAC.00508-12  0.92
2012 Tian Y, Huang T, Li G, Liu J, Wang X, Feng H, Wang J. Retracted: Apoptosis of CT26 colorectal cancer cells induced by Clostridium difficile toxin A stimulates potent anti-tumor immunity. Biochemical and Biophysical Research Communications. 422: 15-21. PMID 22548800 DOI: 10.1016/j.bbrc.2012.04.068  0.52
2012 Oezguen N, Power TD, Urvil P, Feng H, Pothoulakis C, Stamler JS, Braun W, Savidge TC. Clostridial toxins: sensing a target in a hostile gut environment. Gut Microbes. 3: 35-41. PMID 22356854 DOI: 10.4161/gmic.19250  0.92
2012 Krautz-Peterson G, Zhang Y, Chen K, Oyler GA, Feng H, Shoemaker CB. Retargeting Clostridium difficile Toxin B to Neuronal Cells as a Potential Vehicle for Cytosolic Delivery of Therapeutic Biomolecules to Treat Botulism. Journal of Toxicology. 2012: 760142. PMID 21941543 DOI: 10.1155/2012/760142  0.92
2011 Gerhard R, Queisser S, Tatge H, Meyer G, Dittrich-Breiholz O, Kracht M, Feng H, Just I. Down-regulation of interleukin-16 in human mast cells HMC-1 by Clostridium difficile toxins A and B. Naunyn-Schmiedeberg's Archives of Pharmacology. 383: 285-95. PMID 21267712 DOI: 10.1007/s00210-010-0592-8  0.92
2010 Ng J, Hirota SA, Gross O, Li Y, Ulke-Lemee A, Potentier MS, Schenck LP, Vilaysane A, Seamone ME, Feng H, Armstrong GD, Tschopp J, Macdonald JA, Muruve DA, Beck PL. Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology. 139: 542-52, 552.e1-3. PMID 20398664 DOI: 10.1053/j.gastro.2010.04.005  0.92
2004 Feng H, Zeng Y, Graner MW, Whitesell L, Katsanis E. Evidence for a Novel, Caspase-8-Independent, Fas Death Domain-Mediated Apoptotic Pathway. Journal of Biomedicine & Biotechnology. 2004: 41-51. PMID 15123887 DOI: 10.1155/S1110724304308041  0.92
2004 Zeng Y, Graner MW, Feng H, Li G, Katsanis E. Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemia. International Journal of Cancer. Journal International Du Cancer. 110: 251-9. PMID 15069690 DOI: 10.1002/ijc.20115  0.92
2003 Graner MW, Zeng Y, Feng H, Katsanis E. Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunology, Immunotherapy : Cii. 52: 226-34. PMID 12669247 DOI: 10.1007/s00262-002-0359-2  0.92
2003 Zeng Y, Feng H, Graner MW, Katsanis E. Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity. Blood. 101: 4485-91. PMID 12576309 DOI: 10.1182/blood-2002-10-3108  0.92
2003 Feng H, Zeng Y, Graner MW, Likhacheva A, Katsanis E. Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood. 101: 245-52. PMID 12393411 DOI: 10.1182/blood-2002-05-1580  0.92
2002 Feng H, Zeng Y, Graner MW, Katsanis E. Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood. 100: 4108-15. PMID 12393401 DOI: 10.1182/blood-2002-05-1389  0.92
2001 Feng H, Zeng Y, Whitesell L, Katsanis E. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood. 97: 3505-12. PMID 11369644 DOI: 10.1182/blood.V97.11.3505  0.92
2001 He L, Feng H, Raymond A, Kreeger M, Zeng Y, Graner M, Whitesell L, Katsanis E. Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice. Cancer Immunology, Immunotherapy : Cii. 50: 31-40. PMID 11315508  0.92
Show low-probability matches.